Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Curr Psychol ; : 1-13, 2023 May 09.
Article in English | MEDLINE | ID: mdl-37359638

ABSTRACT

Due to changes in the work environment resulting from the COVID-19 pandemic, service employees' behavior, that proactively reshapes the content and meaning of work (i.e., job crafting), is increasingly important. We identified mindfulness as a key individual trait contributing to job crafting in the pandemic context. The purpose of our study was to examine the mediating effect of resilience on the relationship between mindfulness and job crafting, and the moderating effects of perceived organizational health climate and health-oriented leadership on the mindfulness-resilience relationship. We administered two-wave online surveys to 301 South Korean service employees after the onset of COVID-19 (January 20, 2020). Data for mindfulness, resilience, perceived organizational health climate, and health-oriented leadership were collected via participants' self-report in March, 2020. One month later (April, 2020), we obtained their self-ratings of job crafting. Results showed that resilience mediated the relationship between mindfulness and job crafting. The positive relationship between these two variables was more pronounced when perceived organizational health climate was high than when it was low. Perceived organizational health climate further moderated the indirect effect of mindfulness on job crafting through resilience.

2.
J Inequal Appl ; 2017(1): 188, 2017.
Article in English | MEDLINE | ID: mdl-28860689

ABSTRACT

In this paper, we investigate the optimal consumption and portfolio selection problem with negative wealth constraints for an economic agent who has a quadratic utility function of consumption and receives a constant labor income. Due to the property of the quadratic utility function, we separate our problem into two cases and derive the closed-form solutions for each case. We also illustrate some numerical implications of the optimal consumption and portfolio.

3.
Gut Liver ; 10(4): 581-6, 2016 Jul 15.
Article in English | MEDLINE | ID: mdl-27021503

ABSTRACT

BACKGROUND/AIMS: Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) are commonly prescribed for stress ulcer prophylaxis (SUP) in critically ill patients. Several studies have suggested that the use of PPIs is a potential risk factor for Clostridium difficile infection (CDI). We compared the incidences of CDI in the PPI group and H2RA group for SUP in critically ill patients. METHODS: From August 2005 to July 2012, the incidences of CDI were retrospectively analyzed in patients who were admitted directly to intensive care units and stayed for more than 3 days. SUP-related CDI was defined as a CDI diagnosed during the SUP period. Patient clinical data were analyzed to identify potential risk factors for SUP-related CDI. RESULTS: Of the 1,005 patients enrolled (444 patients received PPI and 561 received H2RA), 38 (3.8%) were diagnosed with SUP-related CDI. The incidence of SUP-related CDI was considerably higher in patients who received PPI than in those who received H2RA (6.7% vs 1.8%). PPI use for SUP (odds ratio [OR], 3.3; confidence interval [CI], 1.5 to 7.1; p=0.003) and diabetes mellitus (OR, 2.3; CI, 1.2 to 4.7; p=0.019) were independent risk factors for SUP-related CDI. CONCLUSIONS: PPI therapy is associated with a higher risk of SUP-related CDI than H2RA therapy in critically ill patients.


Subject(s)
Clostridium Infections/chemically induced , Critical Illness/therapy , Cross Infection/chemically induced , Pressure Ulcer/prevention & control , Proton Pump Inhibitors/adverse effects , Aged , Clostridioides difficile/drug effects , Clostridium Infections/epidemiology , Cross Infection/epidemiology , Female , Humans , Incidence , Male , Middle Aged , Odds Ratio , Retrospective Studies , Risk Factors
4.
Yonsei Med J ; 57(1): 138-45, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26632394

ABSTRACT

PURPOSE: The present study aimed to investigate the role of hepatic venous pressure gradient (HVPG) for prediction of long-term mortality in patients with decompensated cirrhosis. MATERIALS AND METHODS: Clinical data from 97 non-critically-ill cirrhotic patients with HVPG measurements were retrospectively and consecutively collected between 2009 and 2012. Patients were classified according to clinical stages and presence of ascites. The prognostic accuracy of HVPG for death, survival curves, and hazard ratios were analyzed. RESULTS: During a median follow-up of 24 (interquartile range, 13-36) months, 22 patients (22.7%) died. The area under the receiver operating characteristics curves of HVPG for predicting 1-year, 2-year, and overall mortality were 0.801, 0.737, and 0.687, respectively (all p<0.01). The best cut-off value of HVPG for predicting long-term overall mortality in all patients was 17 mm Hg. The mortality rates at 1 and 2 years were 8.9% and 19.2%, respectively: 1.9% and 11.9% with HVPG ≤17 mm Hg and 16.2% and 29.4% with HVPG >17 mm Hg, respectively (p=0.015). In the ascites group, the mortality rates at 1 and 2 years were 3.9% and 17.6% with HVPG ≤17 mm Hg and 17.5% and 35.2% with HVPG >17 mm Hg, respectively (p=0.044). Regarding the risk factors for mortality, both HVPG and model for end-stage liver disease were positively related with long-term mortality in all patients. Particularly, for the patients with ascites, both prothrombin time and HVPG were independent risk factors for predicting poor outcomes. CONCLUSION: HVPG is useful for predicting the long-term mortality in patients with decompensated cirrhosis, especially in the presence of ascites.


Subject(s)
Hepatic Veins/physiopathology , Liver Cirrhosis/mortality , Liver Cirrhosis/physiopathology , Liver Failure/mortality , Adult , Aged , Ascites/mortality , Female , Humans , Kaplan-Meier Estimate , Liver Cirrhosis/blood , Liver Cirrhosis/complications , Liver Cirrhosis/diagnosis , Liver Failure/diagnosis , Liver Failure/physiopathology , Male , Middle Aged , Predictive Value of Tests , Prognosis , Proportional Hazards Models , ROC Curve , Retrospective Studies , Risk Factors , Severity of Illness Index , Venous Pressure
5.
J Ultrasound Med ; 34(9): 1621-30, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26269292

ABSTRACT

OBJECTIVES: A concern about methotrexate (MTX)-related liver fibrosis in patients with rheumatoid arthritis (RA) is still unresolved. This study investigated the correlation between liver stiffness and the cumulative MTX dose and the risk factors associated with substantial liver fibrosis assessed by real-time shear wave elastography (SWE), a recently introduced technique to evaluate liver stiffness in patients with RA. METHODS: Data from 185 patients with RA were prospectively collected. Patients were divided into 3 groups according to cumulative MTX dose (group 1, total dose <1500 mg; group 2, 1500-4000 mg, and group 3, >4000 mg) and compared with healthy control participants. A Pearson correlation analysis was performed to evaluate correlations between liver stiffness and other clinical and laboratory variables. Substantial liver fibrosis was defined as liver stiffness of greater than 8.6 kPa by SWE. Associated factors were tested in a multivariate logistic analysis. RESULTS: The mean liver stiffness value in healthy controls was significantly lower than in patients with RA treated with MTX (P< .006), but there was no significant difference among the MTX groups. Liver stiffness and the cumulative MTX dose was not correlated. Substantial liver fibrosis was detected only in 9 patients (4.9%). Multivariate analysis adjusted by age and sex revealed that only a high body mass index (odds ratio, 1.79; 95% confidence interval, 1.34-2.39; P < .001) was associated with liver stiffness of greater than 8.6 kPa. CONCLUSIONS: Substantial liver fibrosis on SWE was observed in about 5% of MTX-treated patients with RA and was associated with only a high body mass index but not with the cumulative MTX dose, suggesting that other comorbidities might have a more important role in liver fibrosis.


Subject(s)
Arthritis, Rheumatoid/drug therapy , Arthritis, Rheumatoid/epidemiology , Elasticity Imaging Techniques/statistics & numerical data , Liver Cirrhosis/diagnostic imaging , Liver Cirrhosis/epidemiology , Methotrexate/therapeutic use , Antirheumatic Agents/therapeutic use , Causality , Chemical and Drug Induced Liver Injury/diagnostic imaging , Chemical and Drug Induced Liver Injury/epidemiology , Comorbidity , Computer Systems , Female , Humans , Incidence , Male , Middle Aged , Reproducibility of Results , Republic of Korea/epidemiology , Risk Factors , Sensitivity and Specificity
6.
Korean J Gastroenterol ; 63(4): 248-52, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24755751

ABSTRACT

Duodenal variceal bleeding in patients with portal hypertension due to cirrhosis or other causes is uncommon. We report on a case of a 55-year-old male with an ectopic variceal rupture at the distal fourth part of the duodenum who presented with massive hematochezia and shock. Shortly after achievement of hemodynamic stability, due to the limitation of an endoscopic procedure, we initially attempted to find the bleeding focus by abdominal computed tomography, which showed tortuous duodenal varices that drained into the left gonadal vein. He was treated with first-line balloon-occluded retrograde transvenous obliteration (BRTO), resulting in a favorable long-term outcome without rebleeding three years later. This case suggests that BRTO may be a first-line therapeutic option for control of ruptured duodenal varices, especially at a distal location.


Subject(s)
Duodenal Diseases/diagnosis , Balloon Occlusion , Duodenal Diseases/diagnostic imaging , Duodenal Diseases/therapy , Embolization, Therapeutic , Gastrointestinal Hemorrhage/therapy , Humans , Male , Middle Aged , Tomography, X-Ray Computed
7.
Korean J Gastroenterol ; 62(3): 179-81, 2013 Sep.
Article in Korean | MEDLINE | ID: mdl-24077630

ABSTRACT

Spontaneous bacterial peritonitis (SBP) is a life-threatening complication in patients with ascites caused by advanced liver disease. While gram negative bacteria, such as Escherichia coli and Klebsiella pneumonia are the common pathogens, Listeria monocytogenes has been recognized as a very rare pathogen. Empirical treatment with third generation cephalosporins does not provide adequate antibiotics coverage against L. monocytogenes. Diagnosis is often delayed as it requires confirmation from ascitic fluid culture. Herein, we describe the first case of SBP caused by L. monocytogenes in a patient with advanced alcoholic liver cirrhosis in Korea. Clinicians should be aware of the atypical pathogens, especially in patients with inadequate response to empirical antibiotics.


Subject(s)
Listeria monocytogenes/physiology , Listeriosis/diagnosis , Liver Cirrhosis, Alcoholic/diagnosis , Peritonitis/diagnosis , Peritonitis/microbiology , Ampicillin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Ascites/microbiology , Humans , Listeriosis/drug therapy , Male , Middle Aged
8.
J Korean Soc Coloproctol ; 28(2): 111-5, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22606652

ABSTRACT

Primary ovarian lymphoma is a rare malignancy whose symptoms or signs are usually nonspecific. In this article, we report a very rare case initially presenting as a rectal submucosal-tumor-like lesion with a defecation disturbance caused by primary ovarian lymphoma with bilateral involvement. A 42-year-old woman visited chungnam national university hospital complaining of persistent defecation disturbance for 6 months. Colonoscopy demonstrated compression of the rectum by an extrinsic mass mimicking a rectal submucosal tumor. Magnetic resonance imaging detected bilateral ovarian tumors, 9.3 cm and 5.4 cm each in diameter, compressing the rectum without enlarged lymph nodes. The diagnosis was established following a bilateral adnexectomy and histological studies of the excised tissue. The tumor was classified as a diffuse large B-cell lymphoma. The patient was prescribed six cycles of standard CHOP (cyclophosphamide, hydroxydaunorubicin, vincristine, prednisolone) regimen and is presently on treatment.

9.
J Ethnopharmacol ; 81(3): 373-9, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12127239

ABSTRACT

This study investigated the anti-angiogenic activities of Cnidium officinale Makino and Tabanus bovinus by using cultured glomerular capillary endothelial cells (GECs), chorioallantoic membrane (CAM) and rat cornea. Treatment of GECs with several concentrations (5-50 microg/ml) of C. officinale Makino and T. bovinus extracts for 24 h inhibited angiotensin II (10(-8) M)-induced increases of [3H]thymidine uptake and cell numbers in a concentration-dependent manner. The extent of inhibitory rate of [3H]thymidine incorporation by C. officinale Makino and T. bovinus at 50 microg/ml was a similar to that by 10(-5) M of retinoic acid. Herbal extracts also conspicuously inhibited the neovascularization. In contrast to the normal branching of vascular vessels, blood vessel patterns in CAMs treated with extracts (50 microg per egg) of C. officinale Makino and T. bovinus were ran parallel to each other without much branching. Moreover, oral administration of herbal extracts (20 mg/kg per day) for 4 weeks significantly inhibited the rat corneal neovascularization induced by suture, and the length of blood vessels in herbal medicine-treated rat cornea was conspicuously lower than that in control animals. A similar inhibitory effect to these was also observed in the rat cornea treated with thalidomide (200 mg/kg per day). These findings indicate that the anti-angiogenic properties of C. officinale Makino and T. bovinus may be one of the pharmacological mechanisms underlying the anti-tumor and anti-metastatic activities of herbal extracts tested in this study.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Cnidium/chemistry , Neovascularization, Physiologic/drug effects , Plant Extracts/pharmacology , Administration, Oral , Allantois/blood supply , Allantois/drug effects , Angiogenesis Inhibitors/administration & dosage , Animals , Antineoplastic Agents/pharmacology , Cell Division/drug effects , Cells, Cultured , Chick Embryo , Chorion/blood supply , Chorion/drug effects , Cornea/blood supply , Cornea/drug effects , Dose-Response Relationship, Drug , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Kidney Glomerulus/cytology , Kidney Glomerulus/drug effects , Male , Plant Extracts/administration & dosage , Rats , Rats, Sprague-Dawley
10.
Arch Pharm Res ; 25(2): 178-83, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12009032

ABSTRACT

A high molecular weight water-soluble chitosan (WSC) with an average molecular weight of 300 kD and a deacethylation level of over 90% was produced using a simple multi-step membrane separation process. It is known that WSC prevents obesity induced by a high-fat diet. Consequently, this study investigated whether or not WSC improved the ovarian dysfunction caused by obesity in mice. The mice were fed a high density protein and lipid diet for 4 weeks, followed by the administration of WSC at 480 mg/kg body weight per day for 4 days. Thereafter, the changes in body weight, ovulation rate, in vivo and in vitro fertilization and embryonic development were measured. WSC markedly reduced the body weight of obese mice fed with a high-fat diet, but not in mice fed with a normal diet. WSC had significant effects on the ovulation rate, both the in vivo and in vitro fertilization rates and embryonic development. These results indicate an improvement in the ovarian and oviduct dysfunction caused by obesity, and suggest an adjustment in the internal secretions and metabolic functions.


Subject(s)
Chitin/analogs & derivatives , Chitin/pharmacology , Dietary Fats/administration & dosage , Fertilization in Vitro , Ovulation/drug effects , Animals , Body Weight/drug effects , Chitosan , Embryonic and Fetal Development/drug effects , Female , Mice , Microinjections , Molecular Weight , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...